X

pharmaceuticals

Infographic: Highlights of Rite Aid’s (RAD) Q3 2021 earnings report

Rite Aid Corporation (NYSE: RAD) reported a decline in third-quarter earnings, despite an increase in revenues, as margins were hurt…

Alexion’s long-term prospects remain intact amid continued focus on rare diseases

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) has stood out in the crowded pharmaceuticals marketplace by developing effective treatments for certain rare health…

Is it the right time to invest in Agilent Technologies (A)?

Agilent Technologies, Inc. (NYSE: A) ended fiscal 2020 on a positive note, bettering its performance consistently after experiencing a slowdown…

COVID-19 vaccine: These pharma companies have also made headway

The month of November has been huge for pharmaceutical companies with many submitting positive results from their clinical trials for…

Merck (MRK) acquires OncoImmune to add another drug to its COVID-19 pipeline

Merck (NYSE: MRK) announced the acquisition of privately-held biopharma company OncoImmune for an upfront payment of $425 million in cash…

Current focus is on scaling up capabilities: 10x Genomics CEO Serge Saxonov

10x Genomics, Inc. (NASDAQ: TXG), a pioneer in single-cell genomics, has been eliciting significant investor interest ever since it went…

Pfizer concludes COVID-19 vaccine trial with efficacy of 95%; will apply for EUA within days

Pfizer Inc. (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) announced the completion of the Phase 3 clinical trial…

Can COVID vaccine be a panacea for Novavax’s (NVAX) growth needs?

The market has been closely following the activities of leading biopharma companies for some time, looking for updates on their…

Biogen (BIIB) might need to revisit pipeline after Alzheimer’s drug setback

The controversy surrounding biotechnology firm Biogen's (NASDAQ: BIIB) Alzheimer's drug Aducanumab took a positive turn last week after the FDA…

Affimed N.V. (AFMD) Q3 2020 Earnings Call Transcript

Affimed N.V.  (NASDAQ: AFMD) Q3 2020 earnings call dated Nov. 10, 2020 Corporate Participants: Alexander Fudukidis -- Head of Investor Relations Adi…

Pfizer (PFE) gains on data showing 90% efficacy for COVID-19 vaccine candidate

Shares of Pfizer Inc. (NYSE: PFE) rallied on Monday after the company reported positive results from its Phase 3 trial…

Infographic: Highlights of Aurora Cannabis’ (ACB) Q1 2021 earnings report

Aurora Cannabis, Inc. (NYSE: ACB) reported a loss for the first quarter of 2021, continuing the recent trend. However, the…

Infographic: Highlights of Cronos Group (CRON) Q3 2020 earnings report

Marijuana company Cronos Group Inc. (NASDAQ: CRON) on Thursday reported financial results for the third quarter of 2020. Revenues increased…

Bristol-Myers Squibb beats in Q3, raises guidance

Bristol-Myers Squibb Company (NYSE: BMY) reported third-quarter 2020 financial results before the market opened on Thursday. The pharmaceutical company reported…

GW Pharmaceuticals stock jumps 20% on Epidiolex strength

GW Pharmaceuticals (NASDAQ: GWPH) reported third-quarter 2020 financial results before the regular trading hours on Tuesday. The company, which specializes…

AbbVie (ABBV) to focus more on pipeline as recovery gathers pace

AbbVie, Inc. (NYSE: ABBV) has been recovering steadily from the virus-related slowdown and latest statistics show that the company's performance…

Eagle Pharmaceuticals Inc. (EGRX) Q3 2020 Earnings Call Transcript

Eagle Pharmaceuticals Inc.  (NASDAQ: EGRX) Q3 2020 Earnings Call dated Nov. 02, 2020 Corporate Participants: Lisa M. Wilson -- Investor Relations -…

AbbVie shares gain after Q3 results beat estimates: Infographic

AbbVie (NYSE: ABBV) reported third-quarter 2020 financial results before the regular trading hours on Friday. The pharmaceutical behemoth reported Q3…

Infographic: Highlights of Gilead Sciences (GILD) Q3 earnings report

Biopharmaceutical company  Gilead Sciences Inc (NASDAQ: GILD) Wednesday said its third-quarter earnings increased, aided by higher revenues. The results also…

Pfizer (PFE) posts mixed results in Q3

Pfizer Inc (NYSE: PFE) reported third-quarter 2020 financial results before the opening bell on Tuesday. The pharmaceutical giant reported a…

Infographic: Highlights of Merck & Co. (MRK) Q3 2020 earnings report

Merck & Co., Inc. (NYSE: MRK) reported stronger than expected earnings and sales for the third quarter of 2020. The…